Integer Holdings Corp (ITGR) shareholders
ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3023% above fair value
$126.70+0.28 (+0.22%)
Close on Nov 13, 2026Market cap $4.31BP/E 42.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
41M of 34M shares
Institutional holders
329
48 new, 34 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 4 sales
Net sold $5.24M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 5,131,033 | 14.70% | 13G (passive) amendment | Jun 30, 2025 |
| Henry R. Kravis Joint filing with Tarheel Investors III L.P. (14.00%), Tarheel Investors III GP LLC (14.00%) and 11 more | 4,753,677 | 14.00% | 13D (active) | Oct 5, 2026 |
| Vanguard Portfolio Management | 2,076,935 | 6.03% | 13G (passive) | Mar 31, 2026 |
| Nomura Holdings Inc Joint filing with Nomura Global Financial Products Inc (5.40%) | 1,821,161 | 5.40% | 13G (passive) | Jun 30, 2026 |
| Vanguard Capital Management | 1,806,396 | 5.25% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ITGR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,353,741 | 15.75% | $500.31M | +47,900 | 0.01% |
| Invesco Ltd. | 2,247,031 | 6.61% | $209.99M | +277,898 | 0.02% |
| Vanguard Portfolio Management LLC | 2,040,469 | 6.00% | $190.68M | −6,497 | 0.01% |
| Dimensional Fund Advisors LP | 1,627,784 | 4.79% | $152.11M | +143,388 | 0.03% |
| Nomura Holdings Inc | 1,554,450 | 4.57% | $145.26M | +1,106,089 | 0.17% |
| Vanguard Capital Management LLC | 1,531,843 | 4.51% | $143.15M | −5,444 | 0.00% |
| State Street Corp | 1,413,174 | 4.16% | $132.02M | +14,888 | 0.00% |
| Morgan Stanley | 1,345,748 | 3.96% | $125.76M | −193,535 | 0.01% |
| Irenic Capital Management LP | 1,264,259 | 3.72% | $118.15M | +596 | 5.67% |
| Earnest Partners LLC | 1,008,519 | 2.97% | $94.25M | −32,629 | 0.34% |
| Hudson Bay Capital Management LP | 1,000,000 | 2.94% | $93.45M | – | 0.25% |
| Citadel Advisors LLC | 965,753 | 2.84% | $90.25M | +272,696 | 0.01% |
| Alliancebernstein L.P. | 913,117 | 2.69% | $80.35M | −390,267 | 0.03% |
| Geode Capital Management, LLC | 879,457 | 2.59% | $82.20M | +45,095 | 0.00% |
| Massachusetts Financial Services Co /Ma/ | 788,214 | 2.32% | $73.66M | −17,660 | 0.02% |
| Healthcare Of Ontario Pension Plan Trust Fund | 778,700 | 2.29% | $72.77M | −40,346 | 0.10% |
| SG Americas Securities, LLC | 645,910 | 1.90% | $60.36M | +254,926 | 0.03% |
| Goldman Sachs Group Inc | 576,830 | 1.70% | $53.90M | +231,231 | 0.00% |
| Manufacturers Life Insurance Company, The | 544,942 | 1.60% | $50.92M | −53,584 | 0.04% |
| Brown Advisory Inc | 544,327 | 1.60% | $50.87M | New | 0.08% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 329 | 41M | 100.0% | 48 / 101 | 130 / 34 | 5M | 3M |
| Q1 2026 | 323 | 39M | 100.0% | 51 / 109 | 112 / 48 | 11M | 5M |
| Q4 2025 | 324 | 37M | 100.0% | 60 / 123 | 103 / 66 | 9M | 10M |
| Q3 2025 | 336 | 39M | 100.0% | 30 / 126 | 132 / 43 | 4M | 5M |
| Q2 2025 | 355 | 40M | 100.0% | 48 / 145 | 109 / 51 | 5M | 5M |
| Q1 2025 | 361 | 40M | 100.0% | 68 / 102 | 130 / 34 | 3M | 3M |
| Q4 2024 | 331 | 40M | 100.0% | 36 / 119 | 119 / 36 | 2M | 2M |
| Q3 2024 | 337 | 39M | 100.0% | 53 / 112 | 115 / 28 | 8M | 2M |
| Q2 2024 | 314 | 39M | 100.0% | 42 / 104 | 111 / 29 | 5M | 4M |
| Q1 2024 | 305 | 38M | 100.0% | 61 / 76 | 120 / 39 | 4M | 3M |
| Q4 2023 | 285 | 37M | 100.0% | 44 / 88 | 106 / 22 | 3M | 2M |
| Q3 2023 | 267 | 36M | 100.0% | 38 / 85 | 89 / 20 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
299 funds held ITGR in Q2 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ITGR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Invesco Small Cap Value Fund | 2,105,208 | 6.19% | $255.17M | 2.30% | Jul 31, 2026 |
| iShares Core S&P Small-Cap ETF | 2,045,844 | 6.02% | $191.18M | 0.17% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,079,637 | 3.18% | $100.89M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 880,761 | 2.59% | $82.31M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 778,146 | 2.29% | $72.72M | 0.04% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 493,287 | 1.45% | $46.10M | 0.07% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 389,592 | 1.15% | $36.41M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 374,489 | 1.10% | $45.39M | 0.13% | Jul 31, 2026 |
| Harbor Small Cap Value Fund | 366,667 | 1.08% | $44.44M | 1.77% | Jul 31, 2026 |
| U.S. Small Cap Value Portfolio | 341,972 | 1.01% | $41.45M | 0.21% | Jul 31, 2026 |
| MFS New Discovery Fund | 332,845 | 0.98% | $29.75M | 1.39% | May 31, 2026 |
| iShares Russell 2000 Value ETF | 321,170 | 0.94% | $30.01M | 0.21% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 312,463 | 0.92% | $29.20M | 0.17% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 292,324 | 0.86% | $27.32M | 0.34% | Jun 30, 2026 |
| Brown Advisory Small-Cap Fundamental Value Fund | 291,112 | 0.86% | $27.20M | 2.20% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Payman Khales | President & CEO, Director | 63,378 | 0.19% | Oct 26, 2026 |
| Joseph W. Dziedzic | President & CEO, Director | 59,202 | 0.17% | Jun 13, 2025 |
| Kirk K. Thor | Chief Human Resources Officer | 7,153 | 0.02% | Sep 16, 2026 |
| Andrew Senn | President, Growth & Innovation | 5,405 | 0.02% | Sep 10, 2026 |
| Milo Stephen Metcalf II | US - EVP, Operations | – | – | Jul 10, 2026 |
| John A. Harris | President, Glob Ops & Manu Tec | 8,657 | 0.03% | Jul 1, 2026 |
| Tommy P. Thomas | VP, Corporate Controller | 4,381 | 0.01% | May 22, 2026 |
| Jim Stephens | President, CRM & Neuro | 6,331 | 0.02% | May 19, 2026 |
| Diron Smith | EVP, Chief Financial Officer | 12,919 | 0.04% | May 12, 2026 |
| Terence Carr | EVP, Qlty & Regulatory Affairs | 1,350 | 0.00% | Mar 25, 2026 |
| Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | 2,434 | 0.01% | Mar 25, 2026 |
| Sanjiv Arora | SVP, Investor Relations | – | – | Apr 9, 2025 |
| McAlister C. Marshall II | SVP, Gen Counsel & Secretary | 6,830 | 0.02% | Feb 25, 2025 |
| Margaret Carthy | EVP, Qlty & Regulatory Affairs | 7,932 | 0.02% | Feb 25, 2025 |
| Michael J. Coyle | Director | 3,322 | 0.01% | May 22, 2026 |
| James Francis Flanagan | Director | 2,377 | 0.01% | May 22, 2026 |
| Filippo Passerini | Director | 31,114 | 0.09% | May 22, 2026 |
| Martin C. Maxwell | Director | 25,106 | 0.07% | May 22, 2026 |
| James F. Hinrichs | Director | 7,424 | 0.02% | May 22, 2026 |
| Donald J. Spence | Director | 18,781 | 0.06% | May 22, 2026 |
| Alvin Tyrone Jeffers | Director | 4,552 | 0.01% | May 22, 2026 |
| Sheila Antrum | Director | 12,069 | 0.04% | May 22, 2026 |
| Cheryl C. Capps | Director | 13,669 | 0.04% | May 22, 2026 |
| Aaron Kapito | Director | 3,338 | 0.01% | May 22, 2026 |
| Pamela G. Bailey | Director | 56,052 | 0.16% | Jan 5, 2026 |
| Jean M. Hobby | Director | 3,794 | 0.01% | May 23, 2025 |
| & Co. Inc. KKR | 10% owner | – | – | Oct 15, 2026 |
| Group Co. Inc. KKR | 10% owner | – | – | Oct 15, 2026 |
| Group Partnership L.P. KKR | 10% owner | 4,753,677 | 13.98% | Oct 15, 2026 |
| Henry R. Kravis | 10% owner | – | – | Oct 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Payman Khales President & CEO, Director | Oct 24, 2026 | Tax withholding | −990 | $126.54 | $125.27K | 63,378 |
| Payman Khales President & CEO, Director | Oct 24, 2026 | Option exercise | +2,514 | – | – | 64,368 |
| Kirk K. Thor Chief Human Resources Officer | Sep 15, 2026 | Sale | −11,767 | $126.23 | $1.49M | 7,153 |
| Kirk K. Thor Chief Human Resources Officer | Sep 14, 2026 | Sale | −19,773 | $126.25 | $2.50M | 18,920 |
| Andrew Senn President, Growth & Innovation | Sep 8, 2026 | Sale | −9,408 | $126.30 | $1.19M | 5,405 |
| Kirk K. Thor Chief Human Resources Officer | Jun 30, 2026 | Tax withholding | −2,409 | $93.45 | $225.12K | 38,693 |
| Kirk K. Thor Chief Human Resources Officer | Jun 30, 2026 | Option exercise | +6,120 | – | – | 41,102 |
| Martin C. Maxwell Director | May 20, 2026 | Award | +1,967 | – | – | 25,106 |
| Aaron Kapito Director | May 20, 2026 | Award | +1,967 | – | – | 3,338 |
| Filippo Passerini Director | May 20, 2026 | Award | +1,967 | – | – | 31,114 |
| Michael J. Coyle Director | May 20, 2026 | Award | +1,967 | – | – | 3,322 |
| Cheryl C. Capps Director | May 20, 2026 | Award | +1,967 | – | – | 13,669 |
| Sheila Antrum Director | May 20, 2026 | Award | +1,967 | – | – | 12,069 |
| James Francis Flanagan Director | May 20, 2026 | Award | +1,967 | – | – | 2,377 |
| Alvin Tyrone Jeffers Director | May 20, 2026 | Award | +1,967 | – | – | 4,552 |
| Jim Stephens President, CRM & Neuro | May 15, 2026 | Option exercise | +1,472 | – | – | 6,331 |
| Jim Stephens President, CRM & Neuro | May 15, 2026 | Tax withholding | −479 | $88.16 | $42.23K | 5,852 |
| Jim Stephens President, CRM & Neuro | May 15, 2026 | Option exercise | +491 | – | – | 4,859 |
| Diron Smith EVP, Chief Financial Officer | May 8, 2026 | Tax withholding | −503 | $88.12 | $44.32K | 12,919 |
| Diron Smith EVP, Chief Financial Officer | May 8, 2026 | Option exercise | +2,063 | – | – | 13,422 |
| John A. Harris EVP, Global Ops and Manufactur | Mar 31, 2026 | Tax withholding | −1,842 | $88.00 | $162.10K | 8,657 |
| John A. Harris EVP, Global Ops and Manufactur | Mar 31, 2026 | Option exercise | +3,837 | – | – | 10,499 |
| Lindsay K. Blackwood SVP, Gen Counsel & Secretary | Mar 24, 2026 | Tax withholding | −1,049 | $86.19 | $90.41K | 2,434 |
| Lindsay K. Blackwood SVP, Gen Counsel & Secretary | Mar 24, 2026 | Option exercise | +1,777 | – | – | 1,777 |
| Lindsay K. Blackwood SVP, Gen Counsel & Secretary | Mar 24, 2026 | Option exercise | +1,706 | – | – | 3,483 |
| Terence Carr EVP, Qlty & Regulatory Affairs | Mar 24, 2026 | Option exercise | +1,350 | – | – | 1,350 |
| Terence Carr EVP, Qlty & Regulatory Affairs | Mar 24, 2026 | Tax withholding | −398 | $86.19 | $34.30K | 952 |
| Tommy P. Thomas VP, Corporate Controller | Mar 13, 2026 | Sale | −825 | $85.00 | $70.13K | 4,381 |
| James Francis Flanagan Director | Mar 12, 2026 | Award | +410 | – | – | 410 |
| Aaron Kapito Director | Mar 12, 2026 | Award | +410 | – | – | 1,371 |
| Payman Khales President & CEO, Director | Feb 24, 2026 | Option exercise | +16,077 | – | – | 51,816 |
| Payman Khales President & CEO, Director | Feb 24, 2026 | Option exercise | +26,983 | – | – | 78,799 |
| Payman Khales President & CEO, Director | Feb 24, 2026 | Tax withholding | −16,945 | $87.10 | $1.48M | 61,854 |
| Andrew Senn President, Cardio & Vascular | Feb 20, 2026 | Tax withholding | −1,447 | $84.85 | $122.78K | 14,813 |
| Andrew Senn President, Cardio & Vascular | Feb 20, 2026 | Award | +2,380 | – | – | 16,260 |
| Andrew Senn President, Cardio & Vascular | Feb 20, 2026 | Award | +2,340 | – | – | 13,880 |
| Payman Khales President & CEO, Director | Feb 20, 2026 | Award | +7,516 | – | – | 40,377 |
| Payman Khales President & CEO, Director | Feb 20, 2026 | Award | +7,389 | – | – | 32,861 |
| Payman Khales President & CEO, Director | Feb 20, 2026 | Tax withholding | −4,638 | $84.85 | $393.53K | 35,739 |
| Jim Stephens President, CRM & Neuro | Feb 20, 2026 | Award | +2,691 | – | – | 5,024 |
| Jim Stephens President, CRM & Neuro | Feb 20, 2026 | Tax withholding | −656 | $84.85 | $55.66K | 4,368 |
| Kirk K. Thor Chief Human Resources Officer | Feb 20, 2026 | Tax withholding | −2,198 | $84.85 | $186.50K | 34,982 |
| Kirk K. Thor Chief Human Resources Officer | Feb 20, 2026 | Award | +4,550 | – | – | 37,180 |
| Kirk K. Thor Chief Human Resources Officer | Feb 20, 2026 | Award | +4,475 | – | – | 32,630 |
| Diron Smith EVP, Chief Financial Officer | Feb 20, 2026 | Tax withholding | −394 | $84.85 | $33.43K | 11,359 |
| Diron Smith EVP, Chief Financial Officer | Feb 20, 2026 | Award | +817 | – | – | 11,753 |
| Diron Smith EVP, Chief Financial Officer | Feb 20, 2026 | Award | +798 | – | – | 10,936 |
| Tommy P. Thomas VP, Corporate Controller | Feb 20, 2026 | Award | +923 | – | – | 4,980 |
| Tommy P. Thomas VP, Corporate Controller | Feb 20, 2026 | Tax withholding | −713 | $84.85 | $60.50K | 5,206 |
| Tommy P. Thomas VP, Corporate Controller | Feb 20, 2026 | Award | +939 | – | – | 5,919 |
| Tommy P. Thomas VP, Corporate Controller | Jan 20, 2026 | Tax withholding | −141 | $85.15 | $12.01K | 4,057 |
| Tommy P. Thomas VP, Corporate Controller | Jan 20, 2026 | Option exercise | +337 | – | – | 4,391 |
| Diron Smith EVP, Chief Financial Officer | Jan 20, 2026 | Option exercise | +292 | – | – | 11,058 |
| Diron Smith EVP, Chief Financial Officer | Jan 20, 2026 | Tax withholding | −72 | $85.15 | $6.13K | 10,138 |
| Kirk K. Thor Chief Human Resources Officer | Jan 20, 2026 | Tax withholding | −225 | $85.15 | $19.16K | 28,155 |
| Kirk K. Thor Chief Human Resources Officer | Jan 20, 2026 | Option exercise | +816 | – | – | 28,750 |
| Payman Khales President & CEO, Director | Jan 20, 2026 | Option exercise | +1,348 | – | – | 26,434 |
| Payman Khales President & CEO, Director | Jan 20, 2026 | Tax withholding | −329 | $85.15 | $28.01K | 25,472 |
| Andrew Senn SVP, Strategy and Business Dev | Jan 20, 2026 | Option exercise | +2,224 | – | – | 12,625 |
| Andrew Senn SVP, Strategy and Business Dev | Jan 20, 2026 | Tax withholding | −724 | $85.15 | $61.65K | 11,540 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
11.89%
3M shares short
Days to cover
4.3
At 1M shares a day
Change since last report
+5.6%
From 3M shares
Short volume, 20 days
45.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Integer's stock actually held short. Settlement fails (shares not delivered on time) peaked at 21 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kirk K. Thor Officer | Sep 15, 2026 | 4,700 | $593.61K | Sep 15, 2026 | Restricted Stock Vesting |
| Kirk K. Thor Officer | Sep 11, 2026 | 31,540 | $3.98M | Sep 11, 2026 | Vested RSU's |
| Andrew Senn Officer | Sep 8, 2026 | 9,408 | $1.19M | Sep 8, 2026 | Restricted Stock Vesting |
| Martin C. Maxwell Director | Jun 5, 2025 | 8,720 | $1.05M | Jun 5, 2025 | Options Granted - 07/02/2015 |
| Donald J. Spence Director | Jun 4, 2025 | 14,739 | $1.77M | Jun 4, 2025 | Option Granted - 10/17/2016 |
| McAlister C. Marshall II Former Officer | Jun 3, 2025 | 6,830 | $819.60K | Jun 3, 2025 | Restricted Stock Vesting |
| Joseph W. Dziedzic Officer | May 1, 2025 | 267,591 | $33.80M | May 1, 2025 | Acquired as compensation -- Restricted Stock Units |
| Joseph W. Dziedzic Officer, Director | May 1, 2025 | 71,384 | $8.98M | May 1, 2025 | Options Granted - 01/04/2016 |
| Martin C. Maxwell Director | Jul 31, 2024 | 4,700 | $560.00K | Jul 31, 2024 | Purchase |
| Jean M. Hobby Director | Jul 31, 2024 | 11,960 | $1.43M | Jul 31, 2024 | Restricted Stock Vesting |
| John A. Harris Officer | Jul 30, 2024 | 3,400 | $420.92K | Jul 30, 2024 | Restricted Stock Vesting |
| John A. Harris Officer | Jun 4, 2024 | 1,521 | $183.18K | Jun 4, 2024 | Restricted Stock Vesting |
| James F. Hinrichs Director | May 24, 2024 | 9,603 | $1.18M | May 24, 2024 | Option Granted - 02/12/2018 |
| Payman Khales Officer | May 10, 2024 | 8,712 | $991.74K | May 10, 2024 | Restricted Stock Vesting |
| John A. Harris Officer | May 7, 2024 | 312 | $35.26K | May 7, 2024 | Restricted Stock Vesting |
See a number that looks wrong?